SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (595)2/18/1999 11:31:00 PM
From: BWAC  Read Replies (1) | Respond to of 1073
 
Richard,

I came here through the CEPH board and read that CEPH was 'on topic due to drug approval, low price, etc. etc.' Or something like that anyway.

Which made me think about some of Genzyme's tracking stocks. Has anyone here ever looked closely at GZMO ($4)for cancer, and better yet GZTR (formerly GENZL at $3)which has two approved, on the market, selling products. Carticel for knee cartilage replacement and Epicel for burn victim skin grafts.